Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus
Condition(s) studied
Investigational drug(s) / intervention(s)
acoustics tests, Questionaries,: acoustics tests at V1 Questionaries at V1 * cognitive * emotional * auditory
MRI: Anatomical and functional MRI at V2
Study summary
the investigators have recently shown that patients with drug-resistant temporal lobe epilepsy who have undergone brain surgery targeting the medial temporal lobe structures were more likely to develop tinnitus postoperatively. This discovery of a vulnerability to tinnitus associated with medial temporal lobe surgery to eliminate drug-refractory epileptic seizures provides a new clinical model of tinnitus, targeting temporal lobe regions as generators or mediators of this hearing disorder. The objective of this project is to study the impact of tinnitus on the cognitive, emotional, psychoacoustic and cerebral functioning associated with this hearing disorder, and to clarify the pathophysiology of tinnitus by comparing different groups of individuals with tinnitus (surgical epileptic patients or non-surgical ORL patients) to matched tinnitus-free groups (surgical tinnitus-free cases and healthy controls volunteer).
Eligibility
Primary outcome measure(s)
- Evaluation of the impact of tinnitus on executive cognitive functioning — at the second visit, maximum 6 month after first visit.
Measurement of executive control using a stroop test in people with and without chronic tinnitus.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Service de Soins de Suite et Réadaptation (SSR) Neurologique, DMU de Neurosciences | Paris | France | Recruiting |
| Hôpital Européen Georges Pompidou | Paris | France | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04717388 on ClinicalTrials.gov ↗ ← All trials in France